Clover Health Investments Corp - Ordinary Shares - Class A Forecast, price target & analysts
Clover Health Investments Corp - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation
Clover Health Investments Corp - Ordinary Shares - Class A Classifications & Recommendation:
Clover Health Investments Corp - Ordinary Shares - Class A Price Target
| Target Price | $3.06 |
| Price | $2.70 |
| Potential |
13.33%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Clover Health Investments Corp - Ordinary Shares - Class A 2026 .
The average Clover Health Investments Corp - Ordinary Shares - Class A target price is $3.06.
This is
13.33%
register free of charge
$3.89
43.89%
register free of charge
$3.03
12.22%
register free of charge
|
|
| A rating was issued by 9 analysts: 6 Analysts recommend Clover Health Investments Corp - Ordinary Shares - Class A to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Clover Health Investments Corp - Ordinary Shares - Class A stock has an average upside potential 2026 of
13.33%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.37 | 1.94 |
| 8.77% | 41.64% | |
| EBITDA Margin | -3.22% | 2.90% |
| 77.09% | 190.10% | |
| Net Margin | -3.14% | -4.61% |
| 81.47% | 46.96% |
5 Analysts have issued a sales forecast Clover Health Investments Corp - Ordinary Shares - Class A 2025 . The average Clover Health Investments Corp - Ordinary Shares - Class A sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Clover Health Investments Corp - Ordinary Shares - Class A EBITDA forecast 2025. The average Clover Health Investments Corp - Ordinary Shares - Class A EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Clover Health Investments Corp - Ordinary Shares - Class A Analysts have issued a net profit forecast 2025. The average Clover Health Investments Corp - Ordinary Shares - Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.09 | -0.18 |
| 79.55% | 100.00% | |
| P/E | negative | |
| EV/Sales | 0.61 |
5 Analysts have issued a Clover Health Investments Corp - Ordinary Shares - Class A forecast for earnings per share. The average Clover Health Investments Corp - Ordinary Shares - Class A EPS is
This results in the following potential growth metrics and future valuations:
Clover Health Investments Corp - Ordinary Shares - Class A...
Current Clover Health Investments Corp - Ordinary Shares - Class A Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Nov 06 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
| Craig-Hallum |
Locked
➜
Locked
|
Locked | Dec 17 2024 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 07 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Nov 06 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Aug 07 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Aug 06 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 03 2025 |
|
Locked
Craig-Hallum:
Locked
➜
Locked
|
Dec 17 2024 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 07 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
